We provided evidence that the TRAIL-resistant U87 and U373 cells revealed the strongest induction of DR5 along with the most pronounced activation of caspases (Fig. 3G–H), supporting the hypothesis that DR5 is an instrumental factor for TRAIL/Olaparib-mediated cell death in high-grade gliomas. The gene discussed is TNFRSF10B; the disease is glioma.